Biogen Net Profit Margin 2006-2019 | BIIB

Current and historical net profit margin for Biogen (BIIB) from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue. Biogen net profit margin for the three months ending June 30, 2019 was .
Biogen Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-06-30 $14.07B $5.29B 37.62%
2019-03-31 $13.81B $4.67B 33.79%
2018-12-31 $13.45B $4.43B 32.94%
2018-09-30 $13.23B $3.19B 24.08%
2018-06-30 $12.87B $2.97B 23.06%
2018-03-31 $12.59B $2.97B 23.54%
2017-12-31 $12.27B $2.54B 20.69%
2017-09-30 $11.84B $3.49B 29.45%
2017-06-30 $11.72B $3.29B 28.10%
2017-03-31 $11.53B $3.48B 30.17%
2016-12-31 $11.45B $3.70B 32.34%
2016-09-30 $11.42B $3.89B 34.04%
2016-06-30 $11.24B $3.82B 33.98%
2016-03-31 $10.94B $3.70B 33.80%
2015-12-31 $10.76B $3.55B 32.96%
2015-09-30 $10.57B $3.60B 34.06%
2015-06-30 $10.30B $3.49B 33.89%
2015-03-31 $10.13B $3.28B 32.37%
2014-12-31 $9.70B $2.94B 30.25%
2014-09-30 $9.03B $2.51B 27.79%
2014-06-30 $8.35B $2.14B 25.64%
2014-03-31 $7.65B $1.92B 25.06%
2013-12-31 $6.93B $1.86B 26.88%
2013-09-30 $6.38B $1.70B 26.60%
2013-06-30 $5.94B $1.61B 27.06%
2013-03-31 $5.64B $1.50B 26.67%
2012-12-31 $5.52B $1.38B 25.01%
2012-09-30 $5.43B $1.39B 25.58%
2012-06-30 $5.35B $1.34B 25.08%
2012-03-31 $5.14B $1.24B 24.19%
2011-12-31 $5.05B $1.23B 24.44%
2011-09-30 $4.94B $1.17B 23.76%
2011-06-30 $4.81B $1.08B 22.38%
2011-03-31 $4.81B $1.08B 22.47%
2010-12-31 $4.72B $1.00B 21.28%
2010-09-30 $4.63B $1.07B 23.14%
2010-06-30 $4.57B $1.09B 23.94%
2010-03-31 $4.45B $0.94B 21.21%
2009-12-31 $4.38B $0.97B 22.18%
2009-09-30 $4.32B $0.87B 20.19%
2009-06-30 $4.29B $0.80B 18.67%
2009-03-31 $4.19B $0.87B 20.64%
2008-12-31 $4.10B $0.78B 19.14%
2008-09-30 $3.92B $0.78B 19.84%
2008-06-30 $3.62B $0.69B 19.08%
2008-03-31 $3.40B $0.67B 19.69%
2007-12-31 $3.17B $0.64B 20.12%
2007-09-30 $2.99B $0.55B 18.29%
2007-06-30 $2.90B $0.58B 20.14%
2007-03-31 $2.79B $0.23B 8.14%
2006-12-31 $2.68B $0.22B 8.13%
2006-09-30 $2.61B $0.17B 6.33%
2006-06-30 $2.50B $0.04B 1.40%
2006-03-31 $2.45B $0.24B 9.85%
2005-12-31 $2.42B $0.16B 6.64%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $43.552B $13.453B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.390B 13.26
Gilead Sciences (GILD) United States $83.434B 10.25
CSL (CSLLY) Australia $71.884B 0.00
Celgene (CELG) United States $69.726B 10.79
Vertex Pharmaceuticals (VRTX) United States $45.637B 49.32
Illumina (ILMN) United States $44.231B 51.97
Regeneron Pharmaceuticals (REGN) United States $31.400B 14.25
Alexion Pharmaceuticals (ALXN) United States $24.338B 12.83
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.848B 49.58
Exact Sciences (EXAS) United States $13.520B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.318B 0.00
Genmab (GNMSF) Denmark $12.400B 69.55
Seattle Genetics (SGEN) United States $11.500B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.427B 0.00
Galapagos (GLPG) Belgium $8.683B 0.00
QIAGEN (QGEN) Netherlands $7.670B 25.19
Bio-Techne Corp (TECH) United States $7.583B 52.39
Guardant Health (GH) United States $6.971B 0.00
Sarepta Therapeutics (SRPT) United States $6.469B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.359B 0.00
BeiGene (BGNE) Cayman Islands $6.268B 0.00
Amarin (AMRN) Ireland $6.162B 0.00
Bluebird Bio (BLUE) United States $5.906B 0.00
Exelixis (EXEL) United States $5.846B 15.20
Moderna (MRNA) United States $5.630B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.894B 0.00
Horizon Pharma Public (HZNP) Ireland $4.850B 12.33
Ascendis Pharma (ASND) Denmark $4.423B 0.00
Repligen (RGEN) United States $4.098B 79.52
Spark Therapeutics (ONCE) United States $4.033B 0.00
Blueprint Medicines (BPMC) United States $3.978B 0.00
China Biologic Products (CBPO) China $3.935B 24.56
Medicines (MDCO) United States $3.864B 0.00
MorphoSys AG (MOR) Germany $3.670B 0.00
Alkermes (ALKS) Ireland $3.587B 0.00
Mirati Therapeutics (MRTX) United States $3.400B 0.00
Immunomedics (IMMU) United States $3.325B 0.00
Emergent Biosolutions (EBS) United States $2.742B 41.19
CRISPR Therapeutics AG (CRSP) Switzerland $2.715B 0.00
Genomic Health (GHDX) United States $2.667B 50.01
Arena Pharmaceuticals (ARNA) United States $2.607B 5.60
Reata Pharmaceuticals (RETA) United States $2.591B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.582B 0.00
Amicus Therapeutics (FOLD) United States $2.503B 0.00
MyoKardia (MYOK) United States $2.461B 0.00
Halozyme Therapeutics (HALO) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.362B 0.00
Acceleron Pharma (XLRN) United States $2.352B 0.00
NeoGenomics (NEO) United States $2.246B 120.17
Myriad Genetics (MYGN) United States $2.105B 22.09
Akcea Therapeutics (AKCA) United States $2.067B 0.00
Cambrex (CBM) United States $2.004B 25.33
Zai Lab (ZLAB) China $1.990B 0.00
Ligand Pharmaceuticals (LGND) United States $1.937B 24.49
Denali Therapeutics (DNLI) United States $1.891B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
UniQure (QURE) Netherlands $1.776B 0.00
Insmed (INSM) United States $1.701B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.547B 0.00
REGENXBIO (RGNX) United States $1.470B 0.00
Coherus BioSciences (CHRS) United States $1.446B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.389B 0.00
Alector (ALEC) United States $1.333B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.331B 0.00
Sangamo Therapeutics (SGMO) United States $1.307B 0.00
Editas Medicine (EDIT) United States $1.275B 0.00
AnaptysBio (ANAB) United States $1.224B 0.00
Fate Therapeutics (FATE) United States $1.183B 0.00
Innoviva (INVA) United States $1.168B 3.37
RA PHARMCTL INC (RARX) United States $1.162B 0.00
Epizyme (EPZM) United States $1.110B 0.00
Athenex (ATNX) United States $1.053B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Twist Bioscience (TWST) United States $0.986B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Cara Therapeutics (CARA) United States $0.949B 0.00
WAVE Life Sciences (WVE) Singapore $0.939B 0.00
ANI Pharmaceuticals (ANIP) United States $0.881B 14.72
Codexis (CDXS) United States $0.861B 0.00
Arvinas (ARVN) United States $0.845B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Principia Biopharma (PRNB) United States $0.823B 429.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.769B 0.00
Cytokineticsorporated (CYTK) United States $0.763B 0.00
Anika Therapeutics (ANIK) United States $0.748B 26.47
Zealand Pharma (ZEAL) Denmark $0.745B 8.64
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Vericel (VCEL) United States $0.711B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.699B 0.00
MiMedx (MDXG) United States $0.597B 0.00
DBV Technologies S.A (DBVT) France $0.591B 0.00
Revance Therapeutics (RVNC) United States $0.590B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.552B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.546B 0.00
Intra-Cellular Therapies (ITCI) United States $0.540B 0.00
Cellectis S.A (CLLS) France $0.539B 0.00
Heska (HSKA) United States $0.539B 69.82
Retrophin (RTRX) United States $0.529B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
UROGEN PHARMA (URGN) United States $0.495B 0.00
Precision BioSciences (DTIL) United States $0.489B 0.00
Syros Pharmaceuticals (SYRS) United States $0.487B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Puma Biotechnology (PBYI) United States $0.458B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.448B 0.00
BioDelivery Sciences (BDSI) United States $0.433B 0.00
Arcus Biosciences (RCUS) United States $0.431B 0.00
CytomX Therapeutics (CTMX) United States $0.420B 0.00
Agenus (AGEN) United States $0.411B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.410B 0.00
Adverum Biotechnologies (ADVM) United States $0.405B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.379B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
AC Immune SA (ACIU) Switzerland $0.366B 27.05
Gritstone Oncology (GRTS) United States $0.352B 0.00
Kadmon Holdings (KDMN) United States $0.351B 0.00
Prothena (PRTA) Ireland $0.351B 0.00
Scholar Rock Holding (SRRK) United States $0.348B 0.00
Theratechnologies (THERF) Canada $0.346B 0.00
Kindred Biosciences (KIN) United States $0.331B 0.00
Albireo Pharma (ALBO) United States $0.327B 0.00
Biofrontera AG (BFRA) Germany $0.324B 483.33
Avid Bioservices (CDMO) United States $0.319B 0.00
Cel-Sci (CVM) United States $0.317B 0.00
Sorrento Therapeutics (SRNE) United States $0.316B 0.00
Clovis Oncology (CLVS) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
ADMA Biologics Inc (ADMA) United States $0.304B 0.00
Dynavax Technologies (DVAX) United States $0.296B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.291B 0.00
Geron (GERN) United States $0.286B 0.00
Cellular Biomedicine (CBMG) United States $0.286B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.270B 0.00
Inovio Pharmaceuticals (INO) United States $0.266B 0.00
MannKind (MNKD) United States $0.265B 0.00
PDL BioPharma (PDLI) United States $0.262B 6.74
Senesco Technologies (ELOX) United States $0.258B 0.00
Seres Therapeutics (MCRB) United States $0.257B 0.00
ChromaDex (CDXC) United States $0.256B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.252B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.243B 0.00
Palatin Technologies (PTN) United States $0.243B 7.13
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.237B 0.00
Spero Therapeutics (SPRO) United States $0.230B 0.00
Athersys (ATHX) United States $0.226B 0.00
Compugen (CGEN) Israel $0.217B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Five Prime Therapeutics (FPRX) United States $0.208B 0.00
Kamada (KMDA) Israel $0.207B 7.91
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.202B 0.00
Cue Biopharma (CUE) United States $0.201B 0.00
EXICURE INC (XCUR) United States $0.199B 0.00
OSMOTICA PHARM (OSMT) United States $0.198B 0.00
CorMedix Inc (CRMD) United States $0.197B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.188B 0.00
Novavax (NVAX) United States $0.181B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.180B 0.00
Enzo Biochem (ENZ) United States $0.173B 0.00
Arsanis (XFOR) United States $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.172B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.167B 0.00
Emmaus Life Sciences (EMMA) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
XOMA (XOMA) United States $0.164B 0.00
Nicox SA (NICXF) France $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Dyadic (DYAI) United States $0.155B 0.00
Alcobra (ARCT) United States $0.154B 0.00
Strongbridge Biopharma (SBBP) United States $0.153B 6.29
BioTime (LCTX) United States $0.151B 10.10
Cerecor (CERC) United States $0.149B 0.00
Abeona Therapeutics (ABEO) United States $0.147B 0.00
Northwest Biotherapeutics (NWBO) United States $0.147B 0.00
PHASEBIO PHARMA (PHAS) United States $0.144B 0.00
Adocia (ADOCY) France $0.140B 0.00
Aptinyx (APTX) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
NantKwest (NK) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.120B 0.00
Aduro Biotech (ADRO) United States $0.108B 0.00
Verastem (VSTM) United States $0.102B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.100B 0.00
Celyad SA (CYAD) Belgium $0.100B 0.00
Checkpoint Therapeutics (CKPT) United States $0.100B 0.00
Arbutus Biopharma (ABUS) Canada $0.096B 0.00
VTv Therapeutics (VTVT) United States $0.096B 0.00
Trevena (TRVN) United States $0.092B 0.00
Mersana Therapeutics (MRSN) United States $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
OvaScience (MLND) United States $0.090B 0.00
Idera Pharmaceuticals (IDRA) United States $0.090B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.083B 0.00
Selecta Biosciences (SELB) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.073B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Orgenesis (ORGS) United States $0.072B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.070B 38.50
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.066B 0.00
Unum Therapeutics (UMRX) United States $0.063B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Prima BioMed (IMMP) Australia $0.056B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
AIT Therapeutics (XAIR) United States $0.052B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
VIVUS (VVUS) United States $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
Stellar Biotechnologies (EDSA) Canada $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.034B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
AEterna Zentaris (AEZS) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.77
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.024B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.023B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Novogen (KZIA) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Novelion Therapeutics (NVLN) Canada $0.017B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00